LoginRegister
    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual TabletsNatco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets
    Lupin gets tentative USFDA nod for Fosaprepitant injectionLupin gets tentative USFDA nod for Fosaprepitant injection
    Biocon commercial rights on biosimilar adalimumab extends to global marketsBiocon commercial rights on biosimilar adalimumab extends to global markets
    Alembic Pharma partners with SPH Group, Adia for Chinese marketAlembic Pharma partners with SPH Group, Adia for Chinese market
    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life SciencesGlenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences
    NPPA to revise ceiling price of Silver Sulphadiazine cream 1 pc; direct manufacturers to furnish dataNPPA to revise ceiling price of Silver Sulphadiazine cream 1 pc; direct manufacturers to furnish...
    Alembic Pharma JV gets EIR from USFDA for Karakhadi facilityAlembic Pharma JV gets EIR from USFDA for Karakhadi facility
    Merck will now be called Procter & Gamble HealthMerck will now be called Procter & Gamble Health
    Pfizer gets USFDA nod for potential blockbuster heart drug TafamidisPfizer gets USFDA nod for potential blockbuster heart drug Tafamidis
    Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorderJacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder
    Medlife acquires medicine delivery startup Myra MedicinesMedlife acquires medicine delivery startup Myra Medicines
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X